Home/EnGen Bio/Mark Alfenito, PhD
MA

Mark Alfenito, PhD

President | CEO

EnGen Bio

Therapeutic Areas

EnGen Bio Pipeline

DrugIndicationPhase
Universal Type A Influenza ProgramPrevention and Treatment of Type A InfluenzaPre-clinical